This article reviews a selection of 50 papers on inflammatory bowel disease published between April 2000 and June 2001. The new information summarized here includes: the discovery of the association of the NOD2 gene with Crohn's disease; the role of bacteria and the modulating effects of probiotics; the inverse association of appendectomy and ulcerative colitis; progress in imaging based on magnetic resonance imaging and leukocyte scintigraphy; assessment of the value of anti-Saccharomyces cerevisiae antibodies in the screening of inflammatory bowel disease and differentiation between ulcerative colitis and Crohn's disease; and risk factors and management of dysplasia and cancer. This article does not review all therapeutic aspects, but focuses on smoking cessation; anti-tumor necrosis factor antibody treatments; the usefulness of measuring erythrocyte 6-thioguanine metabolite levels to optimize purine analogue therapy; strictureplasty; and the long-term results of ileoanal anastomosis.
References
-
1
Hugot J P, Chamaillard M, Zouali H. et al .
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
Nature.
2001;
411
599-603
-
2
Ogura Y, Bonen D K, Inohara N. et al .
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Nature.
2001;
411
603-606
-
3
Hampe J, Cuthbert A, Croucher P J. et al .
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
Lancet.
2001;
357
1925-1928
-
4
Laharie D, Debeugny S, Peeters M. et al .
Inflammatory bowel disease in spouses and their offspring.
Gastroenterology.
2001;
120
816-819
-
5
Pardi D S, Tremaine W J, Sandborn W J. et al .
Early measles virus infection is associated with the development of inflammatory bowel disease.
Am J Gastroenterol.
2000;
95
1480-1485
-
6
Morris D L, Montgomery S M, Thompson N P. et al .
Measles vaccination and inflammatory bowel disease: a national British Cohort Study.
Am J Gastroenterol.
2000;
95
3507-3512
-
7
Sutton C L, Kim J, Yamane A. et al .
Identification of a novel bacterial sequence associated with Crohn's disease.
Gastroenterology.
2000;
119
23-31
-
8
Masseret E, Boudeau J, Colombel J F. et al .
Genetically related Escherichia coli strains associated with Crohn's disease.
Gut.
2001;
48
320-325
-
9
Andersson R E, Olaison G, Tysk C, Ekbom A.
Appendectomy and protection against ulcerative colitis.
N Engl J Med.
2001;
344
808-814
-
10
Jarnerot G, Andersson M, Franzen L.
Laparoscopic appendectomy in patients with refractory ulcerative colitis.
Gastroenterology.
2001;
120
1562-1563
-
11
Bernstein C N, Blanchard J F, Rawsthorne P, Yu N.
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Am J Gastroenterol.
2001;
96
1116-1122
-
12
Grandval P, Barthet M, Desjeux A. et al .
Pseudotumorous chronic pancreatitis associated with inflammatory bowel disease.
Dig Dis Sci.
2001;
46
898-900
-
13
Terashima S, Hoshino Y, Kanzaki N. et al .
Ulcerative duodenitis accompanying ulcerative colitis.
J Clin Gastroenterol.
2001;
32
172-175
-
14
Bitton A, Peppercorn M A, Antonioli D A. et al .
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis.
Gastroenterology.
2001;
120
13-20
-
15
Vermeire S, Joossens S, Peeters M. et al .
Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.
Gastroenterology.
2001;
120
827-833
-
16
Dubinsky M C, Ofman J J, Urman M. et al .
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.
Am J Gastroenterol.
2001;
96
758-765
-
17
Umschaden H W, Szolar D, Gasser J. et al .
Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings.
Radiology.
2000;
215
717-725
-
18
Beets-Tan R G, Beets G L, van der Hoop A G. et al .
Preoperative MR imaging of anal fistulas: does it really help the surgeon?.
Radiology.
2001;
218
75-84
-
19
D'Arienzo A, Scaglione G, Bennato R. et al .
The prognostic value, in active ulcerative colitis, of an increased intensity of colonic perivisceral fat signal on magnetic resonance imaging with ferumoxsil.
Am J Gastroenterol.
2001;
96
481-486
-
20
Bezabeh T, Somorjai R L, Smith I C. et al .
The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
Am J Gastroenterol.
2001;
96
442-448
-
21
Maunoury V, Mordon S, Geboes K. et al .
Early vascular changes in Crohn's disease: an endoscopic fluorescence study.
Endoscopy.
2000;
32
700-705
-
22
Matsuhashi N, Nakajima A, Suzuki A. et al .
Long-term outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn's disease.
Gastrointest Endosc.
2000;
51
343-345
-
23
Perez-Cuadrado E, Molina P erez.
Multiple strictures in jejunal Crohn's disease: push enteroscopy dilation.
Endoscopy.
2001;
33
194
-
24
Esaki M, Matsumoto T, Hizawa K. et al .
Intraoperative enteroscopy detects more lesions but is not predictive of postoperative recurrence in Crohn's disease.
Surg Endosc.
2001;
15
455-459
-
25
Rajan E, Herman L J, Sorbi D. et al .
Topical formalin therapy by means of an endoscopic applicator for control of ileoanal pouch ulcer bleeding.
Gastrointest Endosc.
2000;
52
422-424
-
26
Charron M, di Lorenzo C, Kocoshis S.
Are 99mTc leukocyte scintigraphy and SBFT studies useful in children suspected of having inflammatory bowel disease?.
Am J Gastroenterol.
2000;
95
1208-1212
-
27
Alberini J L, Badran A, Freneaux E. et al .
Technetium-99m HMPAO-labeled leukocyte imaging compared with endoscopy, ultrasonography, and contrast radiology in children with inflammatory bowel disease.
J Pediatr Gastroenterol Nutr.
2001;
32
278-286
-
28
Eaden J A, Abrams K R, Mayberry J F.
The risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut.
2001;
48
526-535
-
29
Bernstein C N, Blanchard J F, Kliewer E, Wajda A.
Cancer risk in patients with inflammatory bowel disease: a population-based study.
Cancer.
2001;
91
854-862
-
30
Askling J, Dickman P W, Karlen P. et al .
Family history as a risk factor for colorectal cancer in inflammatory bowel disease.
Gastroenterology.
2001;
120
1356-1362
-
31
Askling J, Dickman P W, Karlen P. et al .
Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.
Lancet.
2001;
357
262-266
-
32
Heuschen U A, Hinz U, Allemeyer E H. et al .
Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.
Gastroenterology.
2001;
120
841-847
-
33
Eaden J A, Ward B A, Mayberry J F.
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.
Gastrointest Endosc.
2000;
51
123-128
-
34
Hanauer S B.
Surveying surveillance: are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?.
Gastrointest Endosc.
2000;
51
240-242
-
35
Friedman S, Rubin P H, Bodian C. et al .
Screening and surveillance colonoscopy in chronic Crohn's colitis.
Gastroenterology.
2001;
120
820-826
-
36
Cosnes J, Beaugerie L, Carbonnel F, Gendre J P.
Smoking cessation and the course of Crohn's disease: an intervention study.
Gastroenterology.
2001;
120
1093-1099
-
37
Hilsden R J, Hodgins D, Czechowsky D. et al .
Attitudes toward smoking and smoking behaviors of patients with Crohn's disease.
Am J Gastroenterol.
2001;
96
1849-1853
-
38
Ricart E, Panaccione R, Loftus E V. et al .
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.
Am J Gastroenterol.
2001;
96
722-729
-
39
Cuffari C, Hunt S, Bayless T.
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.
Gut.
2001;
48
642-646
-
40
Dubinsky M.
Idiosyncratic adverse reactions to 6-mercaptopurine and azathioprine can be averted by switching to thioguanine (6-TG) in patients with IBD [abstract].
Gastroenterology.
2001;
56
A12
-
41
Colombel J F, Ferrari N, Debuysere H. et al .
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
Gastroenterology.
2000;
118
1025-1030
-
42
Rajapakse R O, Korelitz B I, Zlatanic J. et al .
Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.
Am J Gastroenterol.
2000;
95
684-688
-
43
Gionchetti P, Rizzello F, Venturi A. et al .
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
Gastroenterology.
2000;
119
305-309
-
44
Shanahan F.
Probiotics in inflammatory bowel disease.
Gut.
2001;
48
609
-
45
Steidler L, Hans W, Schotte L. et al .
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
Science.
2000;
289
1352-1355
-
46
Haderslev K V, Tjellesen L, Sorensen H A, Staun M.
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease.
Gastroenterology.
2000;
119
639-646
-
47
Milsom J, Hammerhofer K, Bohm B. et al .
Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease.
Dis Colon Rectum.
2001;
44
1-9
-
48
Young-Fadok T M, Hall-Long K, McConnell E J. et al .
Advantages of laparoscopic resection for ileocolic Crohn's disease.
Surg Endosc.
2001;
15
450-454
-
49
Tichansky D, Cagir B, Yoo E. et al .
Strictureplasty for Crohn's disease: meta-analysis.
Dis Colon Rectum.
2000;
43
911-919
-
50
Regimbeau J M, Panis Y, Pocard M. et al .
Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease.
Dis Colon Rectum.
2001;
44
769-778
-
51
Yu C S, Pemberton J H, Larson D.
Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results.
Dis Colon Rectum.
2000;
43
1487-1496
P. Marteau, M.D.
Service d'Hépato-Gastroenterologie · Hôpital Européen Georges Pompidou
20, rue Leblanc · 759 Paris Cédex 15 · France
Fax: + 33-1-56 09 35 54
Email: philippe.marteau@egp.ap-hop-paris.fr